Skip to main content
. 2021 Jan 27;5(3):pkab012. doi: 10.1093/jncics/pkab012

Figure 3.

Figure 3.

One-year and 2-year progression-free survival (PFS) rates of chemotherapy, or programmed cell death receptor 1 (PD-1) blockade in different programmed cell death ligand 1 (PD-L1) subgroups. A) One-year PFS in treatment-naïve patients. B) One-year PFS in previously treated patients. C) Two-year PFS in treatment-naïve patients. D) Two-year PFS in previously treated patients. Error bars represent 95% confidence intervals for the pooled estimate.